PETS PETMED EXPRESS INC
Retail-Drug Stores and Proprietary Stores · Nasdaq · SEC CIK 1040130 · Fiscal year ends 03/31
Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-17.4%
TTM net income YoY50.6%
TTM EPS YoY51.1%
Revenue 3-yr CAGR-15.2%
Net income 3-yr CAGR—
Margins
Gross margin27.8%
Operating margin-18.0%
Net margin-17.0%
FCF margin-15.4%
EBITDA margin-12.3%
Returns
ROE-90.8%
ROA-34.1%
ROIC (approx.)-366.8%
Asset turnover2.01x
Leverage & solvency
Liabilities / assets71.6%
Debt / equity0.00x
Current ratio0.60x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.83x
Accruals ratio-5.6%
Payout ratio—
Capex / revenue1.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-03-31 | FY20252025-03-31 | FY20242024-03-31 | FY20232023-03-31 | FY20222022-03-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $179.02M | $226.97M | $274.10M | $247.57M | $272.28M |
| Cost of revenue | — | $157.84M | $189.33M | $171.07M | $195.34M |
| Gross profit | $50.22M | $69.14M | $84.77M | $76.50M | $76.94M |
| SG&A expense | $50.73M | $38.65M | $55.25M | $41.71M | $31.11M |
| Operating income | -$58.67M | -$1.53M | -$8.16M | $6.05M | $24.29M |
| Pretax income | -$57.36M | -$587,000 | -$6.27M | $7.45M | $24.18M |
| Income tax | -$73,000 | $5.68M | $1.19M | $2.31M | $5.47M |
| Net income | -$57.29M | -$6.27M | -$7.46M | $5.14M | $18.72M |
| EBITDA | -$49.29M | $5.51M | -$1.11M | $9.60M | $27.03M |
| EPS (basic) | -2.74 | -0.30 | -0.37 | 0.25 | 0.93 |
| EPS (diluted) | -2.74 | -0.30 | -0.37 | 0.25 | 0.92 |
| Dividends declared per share | 0.00 | 0.00 | 0.60 | 1.20 | 1.20 |
| Weighted avg. shares (diluted) | 20.92M | 20.60M | 20.40M | 20.34M | 20.36M |
| Balance sheet | |||||
| Cash & equivalents | $21.41M | $54.72M | $55.30M | $104.09M | $111.08M |
| Receivables | $1.91M | $2.32M | $3.28M | $1.74M | $1.91M |
| Inventory | $13.61M | $16.20M | $28.56M | — | — |
| Current assets | $43.56M | $78.87M | $93.65M | $130.43M | $151.00M |
| PP&E, net | $26.33M | $28.86M | $26.66M | $26.18M | $24.46M |
| Goodwill | $0 | $26.66M | $26.66M | $0 | — |
| Intangibles | $5.49M | $8.05M | $11.20M | $860,000 | $860,000 |
| Total assets | $81.19M | $148.70M | $169.88M | $167.48M | $179.70M |
| Current liabilities | $52.03M | $62.77M | $72.16M | $57.51M | $56.25M |
| Total liabilities | $52.25M | $63.57M | $73.15M | $57.51M | $56.25M |
| Shareholders' equity | $28.94M | $85.13M | $96.73M | $109.97M | $123.45M |
| Shares outstanding | 21.39M | 20.66M | 21.15M | 21.08M | 20.98M |
| Cash flow statement | |||||
| Operating cash flow | -$28.39M | $4.72M | $4.32M | $27.80M | $18.50M |
| Capital expenditure | $4.62M | $5.11M | $4.51M | $5.26M | $1.75M |
| Free cash flow | -$33.01M | -$395,000 | -$194,000 | $22.54M | $16.75M |
| Investing cash flow | -$4.62M | -$5.11M | -$40.67M | -$10.26M | -$1.75M |
| Financing cash flow | -$299,000 | -$181,000 | -$12.44M | -$24.54M | -$24.38M |
| Depreciation & amortization | $9.39M | $7.04M | $7.06M | $3.55M | $2.74M |
| Stock-based compensation | $1.36M | -$6.59M | $6.87M | $6.62M | $4.55M |
| Dividends paid | $21,000 | $181,000 | $12.44M | $24.54M | $24.38M |
| Share buybacks | — | — | — | — | $0 |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.